{
    "data": [
        {
            "id": "694e849314532500015e4eac",
            "title": "How Netflix, Paramount Sparked A $108 Billion Media War For Warner Bros. Discovery",
            "description": "<div><div class=\"sc-gfrmXj kPLDLR\"><!--$--><p class=\"block core-block\"><em>(Editor’s note: This Dec. 26 story has been updated to include the latest developments in the takeover battle)</em></p><!--/$--><!--$--><p class=\"block core-block\">The sale of HBO-owner <strong>Warner Bros. Discovery </strong><a class=\"ticker-link\" data-exchange=\"NASDAQ\" data-ticker=\"WBD\" href=\"https://www.benzinga.com/quote/WBD\" rel=\"noopener\" target=\"_blank\">(NASDAQ:</a><a class=\"ticker\" href=\"https://www.benzinga.com/quote/WBD\" target=\"_blank\">WBD</a>)<!-- --> has become the entertainment and streaming industry’s Game of Thrones, with <strong>Netflix Inc</strong> <a class=\"ticker-link\" data-exchange=\"NASDAQ\" data-ticker=\"NFLX\" href=\"https://www.benzinga.com/quote/NFLX\" rel=\"noopener\" target=\"_blank\">(NASDAQ:</a><a class=\"ticker\" href=\"https://www.benzinga.com/quote/NFLX\" target=\"_blank\">NFLX</a>)<!-- --> and <strong>Paramount Skydance</strong> <a class=\"ticker-link\" data-exchange=\"NASDAQ\" data-ticker=\"PSKY\" href=\"https://www.benzinga.com/quote/PSKY\" rel=\"noopener\" target=\"_blank\">(NASDAQ:</a><a class=\"ticker\" href=\"https://www.benzinga.com/quote/PSKY\" target=\"_blank\">PSKY</a>)<!-- --> battling for control.</p><!--/$--><!--$?--><template id=\"B:2\"></template><div></div><!--/$--><!--$--><p class=\"block core-block\">Here’s an updated timeline of what has happened so far—</p><!--/$--><!--$?--><template id=\"B:3\"></template><div></div><!--/$--><!--$--><ul class=\"wp-block-list\">\n<li><strong>Feb. 17</strong>: Warner Bros. rejects Paramount’s latest bid; gives the company until Feb. 23 to submit its “best and final offer.”</li>\n</ul><!--/$--><!--$--><ul class=\"wp-block-list\">\n<li><strong>Feb. 10</strong>: Paramount <a href=\"https://www.benzinga.com/m-a/26/02/50533077/warner-bros-discovery-deal-drama-deepens-activist-investor-ancora-plans-to-oppose-netflix-offer-as-paramount-sweetens-bid\" target=\"_blank\">revises its offer</a> to include a “ticking fee” to incentivize WBD, payable to its shareholders for any potential delays in receiving regulatory approval for the deal, and a $2.8 billion termination fee payout to Netflix.</li>\n</ul><!--/$--><!--$--><ul class=\"wp-block-list\">\n<li><strong>Jan. 20</strong>: Netflix switches to <a href=\"https://www.benzinga.com/m-a/26/01/50000461/netflix-switches-to-all-cash-offer-for-warner-bros-discovery-amid-board-support#google_vignette\" target=\"_blank\">an all-cash offer</a> for Warner Bros., without increasing the $82.7 billion price</li>\n</ul><!--/$--><!--$--><ul class=\"wp-block-list\">\n<li><strong>Jan. 12</strong>: David Ellison and Paramount move to sue WBD, say they intend to launch a proxy fight; WBD deems the lawsuit “meritless”</li>\n</ul><!--/$--><!--$--><ul class=\"wp-block-list\">\n<li><strong>Jan. 8</strong>: Paramount reaffirms its $30 per share cash offer, saying Netflix’s bid<br/>“unmistakably inferior”</li>\n</ul><!--/$--><!--$--><ul class=\"wp-block-list\">\n<li><strong>Jan</strong>.<strong> 7, 2026</strong>: WBD rejects Paramount’s offer again, saying the bid is \"inferior\" to  Netflix’s offer</li>\n</ul><!--/$--><!--$--><ul class=\"wp-block-list\">\n<li><strong>Dec. 22, 2025</strong>: Larry Ellison, worth more than $240 billion, is backing Paramount's bid with a $40.4 billion personal guarantee. The amended offer follows Warner's sharp criticism of Paramount's $30-per-share proposal, which cited financing opacity and execution risk. Paramount urged shareholders to tender by Jan. 21 and raised its reverse termination fee to $5.8 billion</li>\n</ul><!--/$--><!--$--><ul class=\"wp-block-list\">\n<li><strong>Dec. 17</strong>: Warner Bros. <a href=\"https://www.benzinga.com/markets/large-cap/25/12/49450373/inferior-and-risky-warner-bros-tells-shareholders-to-shun-paramount-skydance-offer\" target=\"_blank\">formally rejects Paramount’s hostile bid</a>, accusing the Ellison family of failing to put money into the deal, and concludes the Netflix offer is far superior</li>\n</ul><!--/$--><!--$--><ul class=\"wp-block-list\">\n<li><strong>Dec. 16</strong>: President <strong>Donald Trump</strong>‘s son-in-law, <strong>Jared Kushner</strong>, whose private equity firm had promised $200 million, <a href=\"https://www.benzinga.com/markets/tech/25/12/49439613/jared-kushners-affinity-partners-pulls-out-of-warner-bros-takeover-fight-report\" target=\"_blank\">withdraws from Paramount's</a> bidding team.</li>\n</ul><!--/$--><!--$--><ul class=\"wp-block-list\">\n<li><strong>Dec. 15</strong>: Netflix seeks to soothe its staff’s concerns and defends Warner Bros deal as a “win”. </li>\n</ul><!--/$--><!--$?--><template id=\"B:4\"></template><div></div><!--/$--><!--$--><ul class=\"wp-block-list\">\n<li><strong>Dec. 8</strong>: Paramount launches the $108 billion hostile bid, with Ellison saying Warner Bros <a href=\"https://www.benzinga.com/m-a/25/12/49275682/behind-paramounts-hostile-108-billion-bid-for-warner-bros-discovery-was-unanswered-texts\" target=\"_blank\">never responded</a> to Paramount’s offer.</li>\n</ul><!--/$--><!--$--><ul class=\"wp-block-list\">\n<li><strong>Dec. 5</strong>: Netflix announces a deal to buy Warner Bros.</li>\n</ul><!--/$--><!--$?--><template id=\"B:5\"></template><div></div><!--/$--><!--$--><ul class=\"wp-block-list\">\n<li><strong>Nov. 20</strong>: The <a href=\"https://www.benzinga.com/m-a/25/11/48970821/hollywood-braces-for-epic-bidding-war-as-paramount-comcast-and-netflix-eye-warner-bros-discovery-who-will-call-cut\" target=\"_blank\">three bidders submit first-round offers</a> for Warner Bros. Discovery.</li>\n</ul><!--/$--><!--$--><p class=\"block core-block\"><em>Image via Shutterstock</em></p><!--/$--><!--$--><div class=\"sc-jHrKIi gTZsSs\"></div><!--/$--><!--$--><div class=\"bz-optimizely-campaign bz-optimizely-campaign-bottom-49592049\" data-nosnippet=\"true\"></div><!--/$--></div></div>",
            "image": "https://www.benzinga.com/files/images/story/2026/02/26/An-Image-That-Combines-The-Logos-Of-Para_1.jpeg",
            "link": "https://www.benzinga.com/m-a/26/02/49592049/how-netflix-paramount-sparked-a-108-billion-media-war-for-warner-bros-discovery",
            "pub_date": "2026-02-26 20:43:47",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "69a03ebd24c37e0001bb4355",
            "title": "Earnings Summary: WAVE Life Sciences Q4",
            "description": "<div><div class=\"sc-gfrmXj kPLDLR\"><!--$--><p class=\"block core-block\">The earnings results for <strong>WAVE Life Sciences</strong> (NASDAQ:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/WVE\" target=\"_blank\">WVE</a>) for Q4 were made public on Thursday, February 26, 2026 at 07:30 AM.</p><!--/$--><!--$--><p class=\"block core-block\">Here's a comprehensive overview of the announcement.</p><!--/$--><!--$--><h3 class=\"block core-block\">Earnings</h3><!--/$--><!--$--><p class=\"block core-block\">WAVE Life Sciences missed estimated earnings by -11.11%, reporting an EPS of $-0.3 versus an estimate of $-0.27.</p><!--/$--><!--$--><p class=\"block core-block\">Revenue was down $66.50 million from the same period last year.</p><!--/$--><!--$--><h3 class=\"block core-block\">Previous Earnings Records</h3><!--/$--><!--$--><p class=\"block core-block\">The company missed on EPS by $0.02 in the last quarter, resulting in a 2.98% increase share price change the following day.</p><!--/$--><!--$--><p class=\"block core-block\">Here's a look at WAVE Life Sciences's past performance:</p><!--/$--><!--$?--><template id=\"B:2\"></template><div></div><!--/$--><!--$--><p class=\"block core-block\">To track all earnings releases for WAVE Life Sciences <a href=\"https://www.benzinga.com/quote/WVE/earnings\" target=\"_blank\">visit their earnings calendar here.</a> </p><!--/$--><!--$--><p class=\"block core-block\">This article was generated by Benzinga's automated content engine and reviewed by an editor.</p><!--/$--></div></div>",
            "image": "https://www.benzinga.com/files/images/story/2025/11/06/analyst_ratings_6.jpg",
            "link": "https://www.benzinga.com/insights/earnings/26/02/50883978/earnings-summary-wave-life-sciences-q4",
            "pub_date": "2026-02-26 20:38:25",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "69a03f2624c37e0001bb438d",
            "title": "BioCryst Pharma: Q4 Earnings Insights",
            "description": "<div><div class=\"sc-gfrmXj kPLDLR\"><!--$--><p class=\"block core-block\"><strong>BioCryst Pharma</strong> (NASDAQ:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/BCRX\" target=\"_blank\">BCRX</a>) announced its Q4 earnings on Thursday, February 26, 2026 at 07:00 AM.</p><!--/$--><!--$--><p class=\"block core-block\">Here's a breakdown of the earnings report.</p><!--/$--><!--$--><h3 class=\"block core-block\">Earnings</h3><!--/$--><!--$--><p class=\"block core-block\">BioCryst Pharma missed estimated earnings by -21.43%, reporting an EPS of $0.055 versus an estimate of $0.07.</p><!--/$--><!--$--><p class=\"block core-block\">Revenue was up $31.75 million from the same period last year.</p><!--/$--><!--$--><h3 class=\"block core-block\">Past Earnings Performance</h3><!--/$--><!--$--><p class=\"block core-block\">In the previous quarter, the company beat on EPS by $0.08, resulting in a 1.46% drop change in the share price the following day.</p><!--/$--><!--$--><p class=\"block core-block\">Here's a look at BioCryst Pharma's past performance:</p><!--/$--><!--$?--><template id=\"B:2\"></template><div></div><!--/$--><!--$--><p class=\"block core-block\">To track all earnings releases for BioCryst Pharma <a href=\"https://www.benzinga.com/quote/BCRX/earnings\" target=\"_blank\">visit their earnings calendar here.</a> </p><!--/$--><!--$--><p class=\"block core-block\">This article was generated by Benzinga's automated content engine and reviewed by an editor.</p><!--/$--></div></div>",
            "image": "https://www.benzinga.com/files/images/story/2025/11/06/analyst_ratings_8.jpg",
            "link": "https://www.benzinga.com/insights/earnings/26/02/50884034/biocryst-pharma-q4-earnings-insights",
            "pub_date": "2026-02-26 20:40:10",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "69a03dc224c37e0001bb4280",
            "title": "Insights into Cheniere Energy Q4 Earnings",
            "description": "<div><div class=\"sc-gfrmXj kPLDLR\"><!--$--><p class=\"block core-block\"><strong>Cheniere Energy</strong> (NYSE:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/LNG\" target=\"_blank\">LNG</a>) announced its Q4 earnings on Thursday, February 26, 2026 at 07:30 AM.</p><!--/$--><!--$--><p class=\"block core-block\">Here's a breakdown of the earnings report.</p><!--/$--><!--$--><h3 class=\"block core-block\">Earnings</h3><!--/$--><!--$--><p class=\"block core-block\">Cheniere Energy beat estimated earnings by 176.68%, reporting an EPS of $10.68 versus an estimate of $3.86.</p><!--/$--><!--$--><p class=\"block core-block\">Revenue was up $1.01 billion from the same period last year.</p><!--/$--><!--$--><h3 class=\"block core-block\">Overview of Past Earnings</h3><!--/$--><!--$--><p class=\"block core-block\">During the previous quarter, the company beat on EPS by $2.03, leading to a 0.23% increase share price change the next day.</p><!--/$--><!--$--><p class=\"block core-block\">Here's a look at Cheniere Energy's past performance:</p><!--/$--><!--$?--><template id=\"B:2\"></template><div></div><!--/$--><!--$--><p class=\"block core-block\">To track all earnings releases for Cheniere Energy <a href=\"https://www.benzinga.com/quote/LNG/earnings\" target=\"_blank\">visit their earnings calendar here.</a> </p><!--/$--><!--$--><p class=\"block core-block\">This article was generated by Benzinga's automated content engine and reviewed by an editor.</p><!--/$--></div></div>",
            "image": "https://www.benzinga.com/files/images/story/2025/11/06/analyst_ratings_3.jpg",
            "link": "https://www.benzinga.com/insights/earnings/26/02/50883767/insights-into-cheniere-energy-q4-earnings",
            "pub_date": "2026-02-26 20:34:14",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "69a03dc724c37e0001bb4281",
            "title": "Earnings Breakdown: Lindblad Expeditions Q4",
            "description": "<div><div class=\"sc-gfrmXj kPLDLR\"><!--$--><p class=\"block core-block\">The Q4 earnings report for <strong>Lindblad Expeditions</strong> (NASDAQ:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/LIND\" target=\"_blank\">LIND</a>) was released on Thursday, February 26, 2026 at 07:30 AM.</p><!--/$--><!--$--><p class=\"block core-block\">Here's what investors need to know about the latest announcement.</p><!--/$--><!--$--><h3 class=\"block core-block\">Earnings</h3><!--/$--><!--$--><p class=\"block core-block\">Lindblad Expeditions missed estimated earnings by -40.62%, reporting an EPS of $-0.45 versus an estimate of $-0.32.</p><!--/$--><!--$--><p class=\"block core-block\">Revenue was up $34.57 million from the same period last year.</p><!--/$--><!--$--><h3 class=\"block core-block\">Past Earnings Performance</h3><!--/$--><!--$--><p class=\"block core-block\">The company beat on EPS by $0.2 in the last quarter, resulting in a 0.4% increase share price change the following day.</p><!--/$--><!--$--><p class=\"block core-block\">Here's a look at Lindblad Expeditions's past performance:</p><!--/$--><!--$?--><template id=\"B:2\"></template><div></div><!--/$--><!--$--><p class=\"block core-block\">To track all earnings releases for Lindblad Expeditions <a href=\"https://www.benzinga.com/quote/LIND/earnings\" target=\"_blank\">visit their earnings calendar here.</a> </p><!--/$--><!--$--><p class=\"block core-block\">This article was generated by Benzinga's automated content engine and reviewed by an editor.</p><!--/$--></div></div>",
            "image": "https://www.benzinga.com/files/images/story/2025/11/06/analyst_ratings_3.jpg",
            "link": "https://www.benzinga.com/insights/earnings/26/02/50883769/earnings-breakdown-lindblad-expeditions-q4",
            "pub_date": "2026-02-26 20:34:18",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        }
    ]
}